| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
HORMONES AND SIGNALING
1Department of Physiology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre; and 2Departments of Gastroenterology, Radboud University Nijmegen Medical Centre and Internal Medicine, Hilversum Hospital, Nijmegen, The Netherlands
Submitted 18 July 2006 ; accepted in final form 5 August 2006
Glucocorticoids, such as prednisolone, are often used in clinic because of their anti-inflammatory and immunosuppressive properties. However, glucocorticoids reduce bone mineral density (BMD) as a side effect. Malabsorption of Ca2+ in the intestine is supposed to play an important role in the etiology of low BMD. To elucidate the mechanism of glucocorticoid-induced Ca2+ malabsorption, the present study investigated the effect of prednisolone on the expression and activity of proteins responsible for active intestinal Ca2+ absorption including the epithelial Ca2+ channel TRPV6, calbindin-D9K, and the plasma membrane ATPase PMCA1b. Therefore, C57BL/6 mice received 10 mg/kg body wt prednisolone daily by oral gavage for 7 days and were compared with control mice receiving vehicle only. An in vivo 45Ca2+ absorption assay indicated that intestinal Ca2+ absorption was diminished after prednisolone treatment. We showed decreased duodenal TRPV6 and calbindin-D9K mRNA and protein abundance in prednisolone-treated compared with control mice, whereas PMCA1b mRNA levels were not altered. Importantly, detailed expression studies demonstrated that in mice these Ca2+ transport proteins are predominantly localized in the first 2 cm of the duodenum. Furthermore, serum Ca2+ and 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] concentrations remained unchanged by prednisolone treatment. In conclusion, these data suggest that prednisolone reduces the intestinal Ca2+ absorption capacity through diminished duodenal expression of the active Ca2+ transporters TRPV6 and calbindin-D9K independent of systemic 1,25(OH)2D3.
1,25-dihydroxyvitamin D3; duodenum; epithelial calcium channel 2; calcium transporter 1
This article has been cited by other articles:
|
|
 |
|
  G. Mazziotti, A. Giustina, E. Canalis, and J. P. Bilezikian Treatment of glucocorticoid-induced osteoporosis Therapeutic Advances in Musculoskeletal Diseases, October 1, 2009; 1(1): 27 - 34. [Abstract] [PDF]
|
|
|
|
 |
|
 G.-S. Lee, K.-C. Choi, and E.-B. Jeung K+-dependent Na+/Ca2+ exchanger 3 is involved in renal active calcium transport and is differentially expressed in the mouse kidney Am J Physiol Renal Physiol, August 1, 2009; 297(2): F371 - F379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Thongon, L.-i. Nakkrasae, J. Thongbunchoo, N. Krishnamra, and N. Charoenphandhu Enhancement of calcium transport in Caco-2 monolayer through PKC{zeta}-dependent Cav1.3-mediated transcellular and rectifying paracellular pathways by prolactin Am J Physiol Cell Physiol, June 1, 2009; 296(6): C1373 - C1382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-H. Kim, G.-S. Lee, E.-M. Jung, K.-C. Choi, G.-T. Oh, and E.-B. Jeung Dexamethasone differentially regulates renal and duodenal calcium-processing genes in calbindin-D9k and -D28k knockout mice Exp Physiol, January 1, 2009; 94(1): 138 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. J. Hoenderop and R. J. M. Bindels Calciotropic and Magnesiotropic TRP Channels Physiology, February 1, 2008; 23(1): 32 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Nilius, G. Owsianik, T. Voets, and J. A. Peters Transient Receptor Potential Cation Channels in Disease Physiol Rev, January 1, 2007; 87(1): 165 - 217. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
